Searched for
ASTRAZENECA NEWS
India a major growth market for Celonis, says senior execThe Germany-based company said it already serves 260 global capability centres (GCCs) in India, counting companies such as Mercedes-Benz, H...- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- China detains AstraZeneca staff in data, drug-import probes: Report"We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," ...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- AstraZeneca to seek US approval of COVID vaccine in 2nd halfThe Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its s...
- EU regulator advices against second AstraZeneca shot in those with blood clotsThe advice for healthcare professionals was provided by the European Medicines Agency (EMA) as part of an ongoing review into rare, but sev...
- Norway should exclude J&J, AstraZeneca from COVID vaccine scheme, says commissionOn April 15, the Norwegian Institute of Public Health said the AstraZeneca vaccine should be dropped entirely but the government sought fur...
- EU sues AstraZeneca over delayed deliveries of COVID-19 vaccine"AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. ...
- AstraZeneca has not reacted yet to EU letter on vaccines - Italian daily CorriereThe European Union member states and the pharmaceutical company are at odds over the delivery of the shots after the group shipped to the b...
- France to recommend mRNA COVID-19 shots as second dose for some after AstraZeneca: MinisterConfidence in the AstraZeneca vaccine has dropped in Europe since a very few, mostly young, recipients of the shot were found to have suffe...
- German cities suspend AstraZeneca vaccine use for under-60sThe decision came after the country's medical regulator announced that it had received a total of 31 reports of rare blood clots in recent ...
- AstraZeneca Covid shots not recommended for under 55s in CanadaManitoba and Quebec provinces were the first to heed the new National Advisory Committee on Immunization and Health (NACI) guidelines, with...
- UK PM Boris Johnson says he will get Oxford/AstraZeneca COVID-19 vaccine very soonBritish Prime Minister Boris Johnson said on Wednesday he would get the Oxford/AstraZeneca COVID-19 shot very soon, voicing his confidence ...
- Canada sure all that COVID-19 vaccines are safe, including AstraZeneca doses: PMCanadian health experts are sure all COVID-19 vaccines being administered in the country are safe, including those made by AstraZeneca PLC,...
- 2020's parting shot: India to roll out COVID-19 vaccine in January"India is a part of 'COVAX'. We will keep giving 50 per cent of everything we make to India and to COVAX at the same time. India has such a...
- 'Really good news': British Health Secretary Matt Hancock welcomes Oxford/AstraZeneca vaccine results"These figures ... shows that the vaccine in the right dosage can be up to 90% effective," British Health Secretary Matt Hancock told Sky N...
- AstraZeneca plunges 13% as Covid-19 drug trial put on holdAstraZeneca began its Phase 3 trial in the US in late August. The US trial was currently taking place at 62 sites across the country.
- Dr Reddy's trades steady, shrugs off legal challengeDRL’s generic version was to be marketed as Ticaflo, according to those in the know.
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
Load More
